Stay updated on Tucatinib Combo in HER2+ LMD Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in HER2+ LMD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated to Revision: v3.0.2 (replacing v3.0.1); removed the 'Back to Top' element.
    Difference
    0.6%
    Check dated 2025-09-14T23:11:52.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.6%
    Check dated 2025-09-07T19:47:19.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as the early termination of a study due to FDA approval of tucatinib for metastatic HER2+ breast cancer. Several outdated study statuses and recruitment dates have also been removed.
    Difference
    35%
    Check dated 2025-08-31T12:38:35.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T05:11:11.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-10T00:51:03.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:09:31.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in HER2+ LMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in HER2+ LMD Clinical Trial page.